Pages that link to "Q28575913"

The following pages link to Potential relevance of alpha(1)-adrenergic receptor autoantibodies in refractory hypertension (Q28575913):

Displaying 45 items.

• Antibodies in the pathogenesis of hypertension (Q26828588) (← links)
• Angiotensin receptor agonistic autoantibodies and hypertension: preeclampsia and beyond (Q27027039) (← links)
• Adrenoceptor alpha 1A (Q28556733) (← links)
• Alpha1A-adrenergic receptor-directed autoimmunity induces left ventricular damage and diastolic dysfunction in rats (Q33535920) (← links)
• Agonistic autoantibodies as vasodilators in orthostatic hypotension: a new mechanism (Q34244290) (← links)
• Sodium chloride drives autoimmune disease by the induction of pathogenic TH17 cells (Q34331407) (← links)
• Antibodies to the α1-adrenergic receptor cause vascular impairments in rat brain as demonstrated by magnetic resonance angiography (Q34364148) (← links)
• The immunological basis of hypertension (Q34683745) (← links)
• Autoimmunity: an underlying factor in the pathogenesis of hypertension (Q35116086) (← links)
• Preventing autoimmunity protects against the development of hypertension and renal injury (Q35159241) (← links)
• Novel retro-inverso peptide inhibitor reverses angiotensin receptor autoantibody-induced hypertension in the rabbit (Q35175458) (← links)
• Receptor-activating autoantibodies and disease: preeclampsia and beyond (Q35707881) (← links)
• Angiotensin II type 1 receptor antibodies and increased angiotensin II sensitivity in pregnant rats (Q36683260) (← links)
• Elevated Transglutaminase Activity Triggers Angiotensin Receptor Activating Autoantibody Production and Pathophysiology of Preeclampsia (Q36836373) (← links)
• Implications of a vasodilatory human monoclonal autoantibody in postural hypotension (Q37234140) (← links)
• B cells as under-appreciated mediators of non-auto-immune inflammatory disease (Q37728724) (← links)
• Drug-like actions of autoantibodies against receptors of the autonomous nervous system and their impact on human heart function (Q37973384) (← links)
• Activating autoantibodies and cardiovascular disease (Q38118625) (← links)
• The potential role of kynurenines in Alzheimer's disease: pathomechanism and therapeutic possibilities by influencing the glutamate receptors. (Q38171958) (← links)
• Agonistic autoantibodies directed against G-protein-coupled receptors and their relationship to cardiovascular diseases (Q38207936) (← links)
• Selectivity of pharmacological tools: implications for use in cell physiology. A review in the theme: Cell signaling: proteins, pathways and mechanisms. (Q38336214) (← links)
• The role of autoantibodies in the syndromes of orthostatic intolerance: a systematic review. (Q38652607) (← links)
• Device-Based Approaches for the Treatment of Arterial Hypertension (Q38722982) (← links)
• Understanding mechanisms of hypertension in systemic lupus erythematosus (Q38777852) (← links)
• Immunosuppression With Mycophenolate Mofetil Attenuates Hypertension in an Experimental Model of Autoimmune Disease (Q38938727) (← links)
• Associations of Variants in the CACNA1A and CACNA1C Genes With Longitudinal Blood Pressure Changes and Hypertension Incidence: The GenSalt Study (Q39083135) (← links)
• Inflammation, Autoimmunity, and Hypertension: The Essential Role of Tissue Transglutaminase (Q39198610) (← links)
• Autoimmune therapeutic chloroquine lowers blood pressure and improves endothelial function in spontaneously hypertensive rats (Q39378416) (← links)
• Agonistic autoantibodies to the α(1) -adrenergic receptor and the β(2) -adrenergic receptor in Alzheimer's and vascular dementia (Q39409827) (← links)
• Immunoadsorption of Agonistic Autoantibodies Against α1-Adrenergic Receptors in Patients With Mild to Moderate Dementia (Q39837503) (← links)
• National Heart, Lung, and Blood Institute Working Group Report on Salt in Human Health and Sickness: Building on the Current Scientific Evidence (Q40690970) (← links)
• Doxazosin attenuates renal matrix remodeling mediated by anti-α1-adrenergic receptor antibody in a rat model of diabetes mellitus (Q41672015) (← links)
• Autoantibodies targeting AT1 receptor from patients with acute coronary syndrome upregulate proinflammatory cytokines expression in endothelial cells involving NF-κB pathway (Q42652420) (← links)
• Association Analysis about HLA-DRB1, -DQB1 Polymorphism and Auto-Antibodies Against α1-Adrenergic Receptors in Chinese Patients with Essential Hypertension (Q42796924) (← links)
• Agonistic antibody to the alpha1-adrenergic receptor mobilizes intracellular calcium and induces phosphorylation of a cardiac 15-kDa protein (Q43291018) (← links)
• Autoantibodies against AT1 and α1-adrenergic receptors predict arterial stiffness progression in normotensive subjects over a 5-year period (Q47447474) (← links)
• Cerebral blood volume estimation by ferumoxytol-enhanced steady-state MRI at 9.4 T reveals microvascular impact of α1 -adrenergic receptor antibodies. (Q48638550) (← links)
• Autoantibodies against angiotensin and adrenergic receptors: more than a biomarker? (Q50077615) (← links)
• Functional autoantibodies in patients with different forms of dementia. (Q52807608) (← links)
• Mechanisms of hypertension in autoimmune rheumatic diseases (Q64283956) (← links)
• Immune mechanisms of hypertension. (Q67405024) (← links)
• Antibodies to cardiac receptors (Q85539839) (← links)
• Adrenergic Autoantibody-Induced Postural Tachycardia Syndrome in Rabbits (Q90235196) (← links)
• Adaptive Immunity in Hypertension (Q92010061) (← links)
• Molecular mechanisms regulating immune responses in thromboangiitis obliterans: A comprehensive review (Q92479800) (← links)